Cite
SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux.
MLA
Li, Lanlan, et al. “SRT1720 Inhibits Bladder Cancer Cell Progression by Impairing Autophagic Flux.” Biochemical Pharmacology, vol. 222, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bcp.2024.116111.
APA
Li, L., Fu, S., Wang, J., Lu, J., Tao, Y., Zhao, L., Fu, B., Lu, L., Xiang, C., Sun, X., Liu, S., Wang, D., & Wang, Z. (2024). SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux. Biochemical Pharmacology, 222, N.PAG. https://doi.org/10.1016/j.bcp.2024.116111
Chicago
Li, Lanlan, Shengjun Fu, Jianliang Wang, Jianzhong Lu, Yan Tao, Liangtao Zhao, Beitang Fu, et al. 2024. “SRT1720 Inhibits Bladder Cancer Cell Progression by Impairing Autophagic Flux.” Biochemical Pharmacology 222 (April): N.PAG. doi:10.1016/j.bcp.2024.116111.